| Verified against primary record | |
| Prior authorisation system | None; removed in 2019[1] |
|---|---|
| Reimbursement requests (2023) | 53 received, 53 granted, 0 refused[1] |
| Average reimbursement processing time | 350 days, against a 90-day legal limit; the longest reported[1] |
| National contact point | Ministry of Health[2] |
| Independently reported | |
| EU patients using the Directive each year | About 200,000, under 0.05 per cent of EU citizens[3] |
| Bands apply only to the rows beneath them. All counts are claims by Cypriot insured persons for care obtained abroad and are not a count of foreign patients treated in Cyprus. With 53 claims, no rate computed from these figures carries much weight, though a grant rate of 100 per cent with no refusals is itself unusual in the collection. No typical cost range is given because no official Cypriot source publishes prices paid by foreign patients. | |
Medical tourism in Cyprus is recorded in the European data through a small number of outbound claims, all of which were granted, and through the longest processing time reported by any country in the collection. Cyprus abolished prior authorisation for cross-border care in 2019. In reference year 2023 it received 53 reimbursement requests, granted all 53 and refused none, taking an average of 350 days to do so against a 90-day legal limit.
No authorisation, no refusals
The Commission records that Cyprus has no prior authorisation system, having removed it in 2019. Cyprus therefore appears in the authorisation tables only as a country without the mechanism, and all its cross-border claims run on the reimbursement route.[1]
Abolishing authorisation goes further than the Directive requires. The Directive permits authorisation on three defined grounds but does not oblige a member state to operate it, and Cyprus is among the states that have chosen not to, alongside Lithuania and Latvia.[5]
On the reimbursement route Cyprus received 53 requests, granted 53 and refused none. A clean 100 per cent grant rate with no refusals at all is unusual in the collection, where most countries refused some share, and with 53 cases it may reflect a small and well-filtered caseload rather than an unusually generous policy.[1]
Three hundred and fifty days
Cyprus reported an average reimbursement processing time of 350 days against a legal limit of 90 days, the longest average in the report. That is close to four times its own deadline, and roughly a year between a patient claiming and the claim being settled.[1]
The report gives no explanation for the Cypriot figure, in contrast to Croatia, where it records the reason for a 70-day average against a 60-day limit. No inference about the cause is drawn here.[1]
The practical significance is considerable for patients. Under the Directive a patient pays the provider and claims afterwards, so a year’s delay means carrying the full cost of treatment for that period. A system that eventually grants every claim but takes 350 days to do so imposes a real financial barrier that approval statistics alone do not show.[5]
Cyprus’s designated national contact point for cross-border healthcare is the Ministry of Health.[2]
What is not measured
Eurostat maintains a collection of hospital discharges of non-residents, with tables for in-patients, day cases, bed days and average length of stay, reporting country of residence where member states can supply it. Individual cell values for Cyprus were not retrievable for this article.[4]
For scale, the European Court of Auditors estimated about 200,000 patients a year using the Directive across the Union, fewer than 0.05 per cent of EU citizens, and found that fewer than 20 per cent of citizens surveyed in 2015 were aware of their cross-border healthcare rights.[3]
Limits of the evidence
These figures describe Cypriot patients obtaining care abroad, not foreign patients treated in Cyprus, for which no official Cypriot count was located. With 53 claims, rates are indicative at best. Cyprus is promoted commercially as a destination for fertility treatment and elective surgery, with a private sector serving patients from Europe and the Middle East; no official Cypriot figure for that activity was found and none has been estimated.
See also
- Medical travel and treatment affordability, the barrier a 350-day settlement creates
- Fertility tourism, among the privately funded services Cyprus is promoted for
- Medical tourism in Lithuania, another member state operating without prior authorisation
- Medical tourism in Croatia, the other state recorded as exceeding its processing limit
- Cross-border healthcare, the framework producing the Cypriot figures
References
- European Commission, Directorate-General for Health and Food Safety. Data on cross-border patient healthcare following Directive 2011/24/EU, reference year 2023. 15 May 2025. Verified against primary record: the report was opened and the record that Cyprus has no prior authorisation system following its removal in 2019, the Cypriot reimbursement row showing 53 requests received, 53 granted and none refused, the 350-day average processing time against the 90-day limit as the longest reported, the absence of any stated explanation for it, and the contrasting explanation given for Croatia were read directly. Retrieved 23 October 2026.
- United Kingdom government publishing service. EEA countries and contact points. Verified against primary record: the list was opened and the designation of the Ministry of Health as Cyprus’s national contact point was read directly. The document does not state a publication date, which is recorded here as a limitation. Retrieved 23 October 2026.
- European Court of Auditors. Special Report 07/2019: EU actions for cross-border healthcare. 2019. Verified against primary record: the report was opened and the annual patient estimate, the share of citizens and the 2015 awareness finding were read. Retrieved 23 October 2026.
- Eurostat. Hospital discharges and length of stay for inpatient and curative care (hlth_hosd), reference metadata. Last updated 15 December 2025. Verified against primary record: the metadata page was opened and the non-resident definition, the statement that country of residence is reported, and the list of non-resident tables were read. Retrieved 23 October 2026.
- European Parliament and Council. Directive 2011/24/EU, Chapter III, Articles 7 and 8. 9 March 2011. Verified against primary record: the chapter text was opened and the reimbursement rule in Article 7 requiring the patient’s own state to reimburse, the structure under which the patient bears the cost and claims afterwards, and the three permitted but not obligatory grounds for prior authorisation in Article 8(2) were read. Retrieved 23 October 2026.
Sourcing note: this entry uses only official sources. No explanation is offered for the 350-day average processing time, because the Commission gives none, and the practical consequence for patients is described from the structure of the Directive rather than from any Cypriot source. No official Cypriot count of foreign patients treated in Cyprus was located, and no figure has been estimated for privately funded treatment.